• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弗里德赖希共济失调:分子机制、氧化还原考虑因素和治疗机会。

Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

机构信息

Mitochondria, Metals and Oxidative Stress Laboratory, Institut Jacques Monod (UMR 7592 CNRS-University Paris-Diderot), Paris, France.

出版信息

Antioxid Redox Signal. 2010 Sep 1;13(5):651-90. doi: 10.1089/ars.2009.3015.

DOI:10.1089/ars.2009.3015
PMID:20156111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2924788/
Abstract

Mitochondrial dysfunction and oxidative damage are at the origin of numerous neurodegenerative diseases like Friedreich ataxia and Alzheimer and Parkinson diseases. Friedreich ataxia (FRDA) is the most common hereditary ataxia, with one individual affected in 50,000. This disease is characterized by progressive degeneration of the central and peripheral nervous systems, cardiomyopathy, and increased incidence of diabetes mellitus. FRDA is caused by a dynamic mutation, a GAA trinucleotide repeat expansion, in the first intron of the FXN gene. Fewer than 5% of the patients are heterozygous and carry point mutations in the other allele. The molecular consequences of the GAA triplet expansion is transcription silencing and reduced expression of the encoded mitochondrial protein, frataxin. The precise cellular role of frataxin is not known; however, it is clear now that several mitochondrial functions are not performed correctly in patient cells. The affected functions include respiration, iron-sulfur cluster assembly, iron homeostasis, and maintenance of the redox status. This review highlights the molecular mechanisms that underlie the disease phenotypes and the different hypothesis about the function of frataxin. In addition, we present an overview of the most recent therapeutic approaches for this severe disease that actually has no efficient treatment.

摘要

线粒体功能障碍和氧化损伤是许多神经退行性疾病的根源,如弗里德里希共济失调和阿尔茨海默病和帕金森病。弗里德里希共济失调(FRDA)是最常见的遗传性共济失调,每 50,000 人中就有 1 人受到影响。这种疾病的特征是中枢和周围神经系统的进行性退化、心肌病和糖尿病发病率的增加。FRDA 是由 FXN 基因第一个内含子中 GAA 三核苷酸重复扩展引起的动态突变引起的。不到 5%的患者是杂合子,另一个等位基因携带点突变。GAA 三核苷酸扩展的分子后果是转录沉默和编码线粒体蛋白 frataxin 的表达减少。frataxin 的精确细胞功能尚不清楚;然而,现在很清楚,患者细胞中的几种线粒体功能不能正常发挥。受影响的功能包括呼吸、铁硫簇组装、铁稳态和氧化还原状态的维持。这篇综述强调了疾病表型的分子机制以及 frataxin 功能的不同假设。此外,我们还介绍了针对这种严重疾病的最新治疗方法的概述,该疾病实际上没有有效的治疗方法。

相似文献

1
Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.弗里德赖希共济失调:分子机制、氧化还原考虑因素和治疗机会。
Antioxid Redox Signal. 2010 Sep 1;13(5):651-90. doi: 10.1089/ars.2009.3015.
2
Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.与弗里德赖希共济失调相关的错义突变对线粒体 frataxin 同工型有不同但协同的影响。
J Biol Chem. 2013 Feb 8;288(6):4116-27. doi: 10.1074/jbc.M112.435263. Epub 2012 Dec 26.
3
Friedreich Ataxia: From the Eye of a Molecular Biologist.弗里德赖希共济失调:分子生物学家视角
Neurologist. 2015 Sep;20(3):51-5. doi: 10.1097/NRL.0000000000000054.
4
Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.Exenatide 可诱导弗里德里希共济失调中的铁蛋白表达并改善线粒体功能。
JCI Insight. 2020 Jan 30;5(2):134221. doi: 10.1172/jci.insight.134221.
5
Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia.GAA·TTC 扩张疾病弗里德里希共济失调的分子机制和治疗方法。
Neurotherapeutics. 2019 Oct;16(4):1032-1049. doi: 10.1007/s13311-019-00764-x.
6
Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.弗里德里希共济失调中的神经退行性变:从缺陷的 frataxin 到氧化应激。
Oxid Med Cell Longev. 2013;2013:487534. doi: 10.1155/2013/487534. Epub 2013 Jul 9.
7
Iron metabolism and mitochondrial abnormalities in Friedreich ataxia.弗里德赖希共济失调中的铁代谢与线粒体异常
Blood Cells Mol Dis. 2002 Nov-Dec;29(3):536-47; discussion 548-52. doi: 10.1006/bcmd.2002.0591.
8
Pathophysiogical and therapeutic progress in Friedreich ataxia.弗里德里希共济失调的病理生理学和治疗进展。
Rev Neurol (Paris). 2014 May;170(5):355-65. doi: 10.1016/j.neurol.2014.03.008. Epub 2014 Apr 29.
9
Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations.携带FXN I151F病理性点突变的小鼠表现出弗里德赖希共济失调蛋白水平降低、类似弗里德赖希共济失调的表型以及线粒体改变。
Cell Mol Life Sci. 2022 Jan 17;79(2):74. doi: 10.1007/s00018-021-04100-5.
10
The displacement of frataxin from the mitochondrial cristae correlates with abnormal respiratory supercomplexes formation and bioenergetic defects in cells of Friedreich ataxia patients.弗里德赖希共济失调患者细胞中线粒体嵴的 frataxin 位移与异常呼吸超级复合物的形成和生物能量缺陷相关。
FASEB J. 2021 Mar;35(3):e21362. doi: 10.1096/fj.202000524RR.

引用本文的文献

1
Frataxin: from the sequence to the biological role.铁调素:从序列到生物学作用
Biophys Rev. 2025 Apr 3;17(2):449-465. doi: 10.1007/s12551-025-01311-z. eCollection 2025 Apr.
2
New and Emerging Drug and Gene Therapies for Friedreich Ataxia.新型和新兴的药物和基因疗法治疗弗里德里希共济失调。
CNS Drugs. 2024 Oct;38(10):791-805. doi: 10.1007/s40263-024-01113-z. Epub 2024 Aug 8.
3
DNA Base Damage Repair Crosstalks with Chromatin Structures to Contract Expanded GAA Repeats in Friedreich's Ataxia.DNA 碱基损伤修复与染色质结构相互作用,可缩小弗里德里希共济失调中扩展的 GAA 重复序列。
Biomolecules. 2024 Jul 8;14(7):809. doi: 10.3390/biom14070809.
4
Targeted Treatment Strategies for Mitochondria Dysfunction: Correlation with Neurological Disorders.靶向治疗线粒体功能障碍策略:与神经紊乱的相关性。
Curr Drug Targets. 2024;25(10):683-699. doi: 10.2174/0113894501303824240604103732.
5
An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease.一项在弗里德里希共济失调患者中的 RNA-seq 研究发现,hsa-miR-148a-3p 可作为该疾病的潜在预后生物标志物。
Hum Genomics. 2024 May 22;18(1):50. doi: 10.1186/s40246-024-00602-y.
6
Recent Advances in the Treatment Strategies of Friedreich's Ataxia: A Review of Potential Drug Candidates and their Underlying Mechanisms.近年来弗里德里希共济失调治疗策略的进展:潜在药物候选物及其潜在机制的综述。
Curr Pharm Des. 2024;30(19):1472-1489. doi: 10.2174/0113816128288707240404051856.
7
Expression and processing of mature human frataxin after gene therapy in mice.经基因治疗后成熟人 frataxin 在小鼠中的表达和加工。
Sci Rep. 2024 Apr 10;14(1):8391. doi: 10.1038/s41598-024-59060-0.
8
Expression and processing of mature human frataxin after gene therapy in mice.小鼠基因治疗后成熟人铁调素的表达与加工
Res Sq. 2023 Dec 28:rs.3.rs-3788652. doi: 10.21203/rs.3.rs-3788652/v1.
9
Quantification of human mature frataxin protein expression in nonhuman primate hearts after gene therapy.基因治疗后非人灵长类动物心脏中人成熟铁蛋白蛋白表达的定量。
Commun Biol. 2023 Oct 27;6(1):1093. doi: 10.1038/s42003-023-05472-z.
10
Neurodegenerative Diseases: New Hopes and Perspectives.神经退行性疾病:新的希望和展望。
Curr Mol Med. 2024;24(8):1004-1032. doi: 10.2174/1566524023666230907093451.

本文引用的文献

1
Progressive GAA.TTC repeat expansion in human cell lines.人类细胞系中 GAA.TTC 重复扩展的渐进性。
PLoS Genet. 2009 Oct;5(10):e1000704. doi: 10.1371/journal.pgen.1000704. Epub 2009 Oct 30.
2
Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.通过对小鼠突变体的分析阐明弗里德赖希共济失调中线粒体铁负荷的机制。
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16381-6. doi: 10.1073/pnas.0906784106. Epub 2009 Sep 4.
3
Biophysical characterization of the iron in mitochondria from Atm1p-depleted Saccharomyces cerevisiae.来自Atm1p缺失型酿酒酵母线粒体中铁的生物物理特性
Biochemistry. 2009 Oct 13;48(40):9556-68. doi: 10.1021/bi901110n.
4
Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities.弗里德里希共济失调:氧化应激和细胞骨架异常。
J Neurol Sci. 2009 Dec 15;287(1-2):111-8. doi: 10.1016/j.jns.2009.08.052. Epub 2009 Sep 12.
5
The dorsal root ganglion in Friedreich's ataxia.弗里德里希共济失调中的背根神经节。
Acta Neuropathol. 2009 Dec;118(6):763-76. doi: 10.1007/s00401-009-0589-x. Epub 2009 Aug 30.
6
The yeast iron regulatory proteins Grx3/4 and Fra2 form heterodimeric complexes containing a [2Fe-2S] cluster with cysteinyl and histidyl ligation.酵母铁调节蛋白Grx3/4和Fra2形成含有[2Fe-2S]簇的异二聚体复合物,该簇通过半胱氨酰和组氨酰连接。
Biochemistry. 2009 Oct 13;48(40):9569-81. doi: 10.1021/bi901182w.
7
Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen.用于弗里德赖希共济失调高通量药物筛选的铁调素敲低细胞模型的局限性。
BMC Neurol. 2009 Aug 24;9:46. doi: 10.1186/1471-2377-9-46.
8
Frataxin deficiency induces Schwann cell inflammation and death.铁调素缺乏会引发施万细胞炎症和死亡。
Biochim Biophys Acta. 2009 Nov;1792(11):1052-61. doi: 10.1016/j.bbadis.2009.07.011. Epub 2009 Aug 10.
9
Function and biogenesis of iron-sulphur proteins.铁硫蛋白的功能与生物合成
Nature. 2009 Aug 13;460(7257):831-8. doi: 10.1038/nature08301.
10
Deficiency in frataxin homologue YFH1 in the yeast Pichia guilliermondii leads to missregulation of iron acquisition and riboflavin biosynthesis and affects sulfate assimilation.酵母毕赤酵母中同源物 YFH1 的缺陷导致铁摄取和核黄素生物合成的失调,并影响硫酸盐同化。
Biometals. 2009 Dec;22(6):1051-61. doi: 10.1007/s10534-009-9256-x.